Reposted by Sarah BlagdenEric Topol @erictopol.bsky.social · 24/09/2025The projected rise in global cancer deaths 1990 —5.9 million 2023—10.4 million 2050—18.8 million is yet another reason we need to get primary prevention into high gear, which is now possible but not getting done www.thelancet.com/journals/lan... 25481145
Reposted by Sarah BlagdenCancer Research UK City of London Centre @cruk-cityoflondon.bsky.social · 14/04/2025Join our Prevention Primer on 24 June and grow your knowledge ahead of @cancerresearchuk.org's #PrevConf25. Hear from Prof Peter Sasieni, @sarahblagden.bsky.social, @wtklab.bsky.social and others, inc lab scientists, clinicians, behavioural scientists and epidemiologists. bit.ly 014
Sarah Blagden @sarahblagden.bsky.social · 11/02/2025Following @eileenparkes.bsky.social lead, I asked ChatGPT to show me at work. Bang on. Uncanny 040
Reposted by Sarah BlagdenPatrick McGuire @handle.invalid · 30/01/2025Oxford and GSK launch £50million programme to advance novel cancer research oxfordbrc.nihr.ac.uk/oxford-and-g... Thanks to @sarahblagden.bsky.social & colleagues at @oxfordcancer.bsky.social Research Is Where Hope Startsoxfordbrc.nihr.ac.ukOxford and GSK launch £50million programme to advance novel cancer research | NIHR Oxford Biomedical Research Centre 061
Reposted by Sarah BlagdenUniversity of Oxford Department of Oncology @oncology.ox.ac.uk · 27/01/2025@ox.ac.uk & GSK launch £50million immuno-prevention programme to advance novel cancer research The programme, led by Prof. @sarahblagden.bsky.social of @oncology.ox.ac.uk, unites expertise from four departments across the University to explore the potential of cancer prevention through vaccination⬇️cancer.ox.ac.ukOxford and GSK launch £50million immuno-prevention programme to advance novel cancer researchGlobal biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent ... 053
Reposted by Sarah BlagdenThanh Neville, MD, MSHS @thanh-neville.bsky.social · 06/12/2024Thank you #vaccines. Thank you #publichealth. #medsky wapo.st/3Zm23SUwapo.stCervical cancer deaths drop among younger women; study credits HPV vaccineThe HPV vaccine has led to a significant drop in cervical cancer deaths among younger women, with a 62 percent decline in mortality over the last decade. 718939
Sarah Blagden @sarahblagden.bsky.social · 28/11/2024Should grant funding be randomly allocated? Yes, according to schemes funded by British Academy/Leverhulme and Wellcome IFRC. Luck versus Rigour?media.tenor.coma slot machine that says do n't gamble with lives on itALT: a slot machine that says do n't gamble with lives on it 141
Reposted by Sarah BlagdenTim Fenton @timfenton10.bsky.social · 16/11/2024Ok first post on Bluesky and it’s a science one… New paper out from the lab! APOBEC genes protect us from viral infection but go rogue in cancer. Here we shed new light on how these important genes are regulated, offering clues as to what goes wrong in cancer. www.embopress.org/doi/full/10....embopress.orgDifferentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma | The EMBO JournalimageimageAPOBEC3A and APOBEC3B encode DNA editing enzymes with anti-viral roles that generate somatic mutations in cancer. This study provides insight into their expression in healthy and cancerous e... 0247
Reposted by Sarah BlagdenThe Institute of Cancer Research @icr.ac.uk · 16/11/2024📰BREAKING: The Man Van can diagnose #ProstateCancer in at-risk groups earlier and more affordably than the GP route. Find out more about the research into the mobile health clinic, presented at #LGCW2024 ⤵️ www.icr.ac.uk/news-archive...icr.ac.uk 1185
Sarah Blagden @sarahblagden.bsky.social · 16/11/2024(…taps mike nervously)..well hello there Bluesky. Any scientists, oncologists or cancer biologists in the room? 5110